SenzaGen elected winner at Gasellsprånget in Malmö

After a thrilling presentation and questioning round, SenzaGen was elected the winner at the local edition of Gasellsprånget in Malmö, Sweden. SenzaGen now has the opportunity to win Gasellsprånget on a national level at the finale in Gothenburg, on May 25.

On May 11, the Swedish newspaper Dagens Industri hosted the local edition of Gasellsprånget in Malmö, Sweden. A competition which names the fastest growing companies in Sweden. The event was hosted at Clarion Hotel & Congress Malmö Live where participants got the opportunity to listen to presentations about entrepreneurship and development in the region, as well as mingle and network. SenzaGen was one of two companies who, during the evening, had the opportunity to present their company to the audience and a panel experts. After a round of questions from the experts, the audience voted and announced SenzaGen as the winner of Gasellsprånget Malmö.

-This feels like a great win and shows that there are many who believe in us, our business model and the team that we have put together to take the company forward. This event was a very good and exciting environment to pitch in, with many interesting questions from the panel of experts. I am delighted and overwhelmed by all who voted for us, says Anki Malmborg Hager, CEO of SenzaGen.

Two finalists, selected by a jury, will now move forward and get to compete in the national finale at Gasellträffen in Gothenburg, on May 25. Based on the jury’s deliberation, analysis of the companies and an on-stage company presentation, the jury will select the finalist with the best opportunity to become a Supergasell within a 5-year-period.

For more information:
Anki Malmborg Hager,
CEO, SenzaGen AB
E-mail: amh@senzagen.com
Phone: +46 768 284822

Tags:

About Us

About SenzaGen SenzaGen makes it possible to replace animal experiments with in vitro genetic testing to determine the allergenicity of the chemicals we come into contact with in our daily lives, such as for example in cosmetics, pharmaceuticals, food products and dyes. The company's patented tests are the most reliable on the market and provide more information than traditional evaluation methods. We ourselves sell the tests in Sweden and the USA, and we sell through partners in several other countries. Over the next few years the company will expand geographically, make alliances with more distribution partners and launch further unique tests. SenzaGen has its headquarters in Lund in Sweden and a subsidiary in San Francisco, USA. For more information visit www.senzagen.com About GARD GARD is a group of tests for assessing chemical skin sensitizers. The tests make use of genetic biomarkers for more than 200 genes which cover the entire immune reaction and are relevant to predicting the risk of hypersensitivity. The tests have up to 90% reliability. This compares with the current predominant test method, experiments on mice, which has an accuracy of 70-75%. SenzaGen's tests are also capable of measuring the potency of a substance's allergenic properties. Consequently GARD tests provide a much more comprehensive basis for determining whether a substance should be classified as an allergen than current testing methods.

Subscribe

Media

Media

Documents & Links